Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the European Union (EU), with an option for the EC to request up to an additional 900 million doses.
Pfizer and BioNTech to supply the European Union with up to 1.8 billion additional doses of COMIRNATY®
May 26, 2021
![Pfizer and BioNTech to supply the European Union with up to 1.8 billion additional doses of COMIRNATY®](https://www.worldpharmanews.com/images/logo/pfizer.png)